IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 117
Titolo Data di pubblicazione Autore(i) File
Increase in leukocyte count over time predicts thrombosis in patients with low-risk essential thrombocythemia. 1-gen-2009 Passamonti, Francesco; Rumi, Elisa; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndrome 1-gen-2009 DELLA PORTA, MATTEO GIOVANNI; Malcovati, Luca; Boveri, E; Travaglino, E; Pietra, D; Pascutto, C; Passamonti, Francesco; Invernizzi, Rosangela; Castello, Alessandro; Magrini, Umberto; Lazzarino, Mario; Cazzola, Mario
Clinical relevance of JAK2 (V617F) mutant allele burden 1-gen-2009 Passamonti, Francesco; Rumi, Elisa
Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations. 1-gen-2009 Tefferi, A; Passamonti, Francesco
Blood p50 evaluation enhances diagnostic definition of isolated erythrocytosis. 1-gen-2009 Rumi, Elisa; Passamonti, Francesco; Pagano, L; Ammirabile, M; Arcaini, Luca; Elena, Chiara; Flagiello, A; Tedesco, R; Vercellati, C; Marcello, Ap; Pietra, D; Moratti, Remigio; Cazzola, Mario; Lazzarino, Mario
Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis. 1-gen-2009 Malcovati, Luca; DELLA PORTA, MATTEO GIOVANNI; Pietra, D; Boveri, E; Pellagatti, A; Gallì, A; Travaglino, E; Brisci, A; Rumi, Elisa; Passamonti, Francesco; Invernizzi, Rosangela; Cremonesi, L; Boultwood, J; Wainscoat, Js; Hellström Lindberg, E; Cazzola, Mario
Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference. 1-gen-2009 Barosi, G; Birgegard, G; Finazzi, G; Griesshammer, M; Harrison, C; Hasselbalch, Hc; Kiladjian, Jj; Lengfelder, E; Mcmullin, Mf; Passamonti, Francesco; Reilly, Jt; Vannucchi, Am; Barbui, T.
Survival in young patients with intermediate-/high-risk myelofibrosis: Estimates derived from databases for non transplant patients 1-gen-2009 Siragusa, S; Passamonti, Francesco; Cervantes, F; Tefferi, A.
Transfusion-dependency at presentation and its acquisition in the first year of diagnosis are both equally detrimental for survival in primary myelofibrosis--prognostic relevance is independent of IPSS or karyotype. 1-gen-2010 Tefferi, A; Siragusa, S; Hussein, K; Schwager, Sm; Hanson, Ca; Pardanani, A; Cervantes, F; Passamonti, Francesco
Dynamic International Prognostic Scoring System (DIPSS) predicts progression to acute myeloid leukemia in primary myelofibrosis. 1-gen-2010 Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, Elisa; Cazzola, Mario; Tefferi, A.
A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment) 1-gen-2010 Passamonti, Francesco; Cervantes, F; Vannucchi, Am; Morra, E; Rumi, Elisa; Pereira, A; Guglielmelli, P; Pungolino, E; Caramella, M; Maffioli, M; Pascutto, C; Lazzarino, Mario; Cazzola, Mario; Tefferi, A.
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 1-gen-2010 Arcaini, Luca; Merli, Michele; Passamonti, Francesco; Rizzi, Silvia; Ferretti, V; Rattotti, Sara; Pascutto, C; Paulli, Marco; Lazzarino, Mario
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 1-gen-2010 Zibellini, S; Capello, D; Forconi, F; Marcatili, P; Rossi, D; Rattotti, Sara; Franceschetti, S; Sozzi, E; Cencini, E; Marasca, R; Baldini, L; Tucci, A; Bertoni, F; Passamonti, Francesco; Orlandi, E; Varettoni, M; Merli, Michele; Rizzi, Silvia; Gattei, V; Tramontano, A; Paulli, Marco; Gaidano, G; Arcaini, Luca
Deletions of the transcription factor Ikaros in myeloproliferative neoplasms 1-gen-2010 Jäger, R; Gisslinger, H; Passamonti, Francesco; Rumi, Elisa; Berg, T; Gisslinger, B; Pietra, D; Harutyunyan, A; Klampfl, T; Olcaydu, D; Cazzola, Mario; Kralovics, R.
Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation. 1-gen-2010 Rumi, Elisa; Passamonti, Francesco; Arcaini, Luca; Bernasconi, Paolo; Elena, Chiara; Pietra, D; Brisci, A; Arbustini, Eloisa; Cazzola, Mario; Lazzarino, Mario
Validation of cytogenetic-based risk stratification in primary myelofibrosis. 1-gen-2010 Rumi, Elisa; Passamonti, Francesco; Bernasconi, Paolo; Arcaini, Luca; Pietra, D; Elena, Chiara; Boveri, E; Pascutto, C; Cazzola, Mario; Lazzarino, Mario
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 1-gen-2010 Merli, Michele; Arcaini, Luca; Boveri, E; Rattotti, Sara; Picone, C; Passamonti, Francesco; Tenore, A; Sozzani, L; Lucioni, Marco; Varettoni, M; Rizzi, Silvia; Morello, L; Ferretti, V; Pascutto, C; Paulli, Marco; Lazzarino, Mario
Mutational status of myeloproliferative neoplasms. 1-gen-2010 Rumi, Elisa; Elena, Chiara; Passamonti, Francesco
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications. 1-gen-2010 Passamonti, Francesco; Rumi, Elisa; Pietra, D; Elena, Chiara; Boveri, E; Arcaini, Luca; Roncoroni, E; Astori, C; Merli, M; Boggi, S; Pascutto, C; Lazzarino, Mario; Cazzola, Mario
Impact of treatment-related liver toxicity on the outcome of HCV-positive non-Hodgkin's lymphomas. 1-gen-2010 Arcaini, Luca; Merli, M; Passamonti, Francesco; Bruno, Raffaele; Ebrusamolino, E; Sacchi, P; Rattotti, S; Orlandi, E; Rumi, Elisa; Ferretti, V; Rizzi, S; Meli, E; Pascutto, C; Paulli, Marco; Lazzarino, Mario
Mostrati risultati da 41 a 60 di 117
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile